Groowe Groowe / Newsroom / BIIB
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BIIB News

Biogen Inc. Common Stock

Alzheimer's Therapeutics Market Research Report 2026-2036: Growing Global Burden of Alzheimer's Continues to Drive Demand - Opportunities in Surge in Merger & Acquisitions, Increasing R&D Investments

globenewswire.com
BIIB

Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research

prnewswire.com
TMO MRK BIO BIIB AMGN GILD REGN CRSP NTLA BMY ABBV AZN NVS PFE JNJ MRNA BNTX COR STEM ALGN EXAS MDLZ BHC CVS UNH CI CNC ELAN ZTS ISRG QRVO SWKS AVGO QCOM INTC MSFT GOOG AMZN IBM ORCL CRM ADBE NFLX DIS MCD SBUX KO PEP PG JPM BAC WFC C GS MS AXP V MA HD LOW COST TGT WMT BBY CMCSA VZ T XOM CVX SIRI UBER LYFT NVDA AMD MU AMAT LRCX ASML ADI TXN QGEN ILMN VRTX EDIT BEAM SRPT ACAD ALKS MDT SYK DHR GOOGL

U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs

globenewswire.com
BMY GILD JNJ SNY TAK AMGN AZN LLY MRK PFE REGN VRTX ABBV ALNY AMTX BIIB BMRN CRSP EXAS INCY IONS JAZZ NTLA PTC RGEN XOM

Molecular Instruments Announces Fully Ambient-Temperature HCR™ Pro RNA-ISH on the BOND-III, Setting a New Standard for Clinical Automation

businesswire.com
BIIB

Molecular Instruments Announces Fully Ambient-Temperature HCR™ Pro RNA-ISH on the BOND-III, Setting a New Standard for Clinical Automation

businesswire.com
BIIB

Muscular Dystrophy Association Announces Łukasz Sznajder, PhD, MSc, to Receive Inaugural MDA Research Momentum Award

globenewswire.com
ARX BIIB BBIO NVS RGNX

Global Oligonucleotide Therapeutics Market Set to Surge to USD 17.70 Billion by 2030 | MarketsandMarkets™

globenewswire.com
BIIB ALNY SRPT

Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™

prnewswire.com
BIIB CHRW

Alzheimer's Therapeutics Market to Reach USD 10.4 Billion by 2036 as Disease-Modifying Immunotherapies Transform Treatment Paradigms

accessnewswire.com
ABBV BMY JNJ LLY NVS REGN BIIB

Biogen Announces Board Chair Transition

globenewswire.com
BIIB ARE EXEL